Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology

Cited by (147)

Items 101–147 of 147

1. Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study
   Coralie Amadou, Vincent Melki, Jennifer Allain, Sylvaine Clavel, D. Gouet, Lucy Chaillous, Bogdan Catargi, Pauline Schaeplynck-Belicard, Catherine Petit, Charles H. Thivolet et al. · 2023 · PLoS ONE
2. The Effect of Omnipod 5 Automated Insulin Delivery on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes
   Kevin J. Scully, Michelle Reed, Julia L. Douvas, Melissa S. Putman, Brynn E. Marks · 2025 · Diabetes Technology & Therapeutics
3. To sleep or not to sleep: An Italian Control-IQ-uestion
   Marta Bassi, Marina Francesca Strati, Valentina Andreottola, Maria Grazia Calevo, Giuseppe d’Annunzio, Mohamad Maghnie, Nicola Minuto · 2022 · Frontiers in Endocrinology
4. Differences in positive expectancy of hybrid closed loop (HCL) insulin delivery systems do not explain racial differences in HCL use
   J Grundman, AMANDA G. PERKINS, Maureen C. Monaghan, Seema Meighan, Randi M. Streisand, Brynn E. Marks · 2023 · Journal of Clinical & Translational Endocrinology
5. The Tandem Control-IQ advanced hybrid system improves glycemic control in children under 18 years of age with type 1 diabetes and night rest in caregivers
   Andrés Mingorance Delgado, Fernando Lucas · 2023 · Endocrinología Diabetes y Nutrición (English ed )
6. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers
   Amy Morrison, Peter Alexander Senior, Tania M. Bubela, Kate Farnsworth, Holly O. Witteman, Anna P. Lam · 2022 · Canadian Journal of Diabetes
7. Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology
   Lía Nattero‐Chávez, MAR LORENZO, María Soledad Ruiz de Adana, Olga Simó‐Servat, Mercè Abad, Carmen Quirós, María Durán Martínez, Alejandra Quintero Tobar, Ane Bayona, Teresa Ruiz Gracia et al. · 2026 · Therapeutic Advances in Endocrinology and Metabolism
8. Diabetes distress, the mediator of the poor glycemic control and depression: A meta-analysis
   Hyder Osman Mirghani · 2024 · World Journal of Meta-Analysis
9. Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes
   Maite E. Del Valle Rolón, Elizabeth A. Brown, Risa M. Wolf · 2023 · Pediatric Diabetes
10. Improved Glycemia and Quality of Life Among Loop Users: Analysis of Real-world Data From a Single Center
    Amy Morrison, Kimberley Chong, Valerie Lai, Kate Farnsworth, Peter Alexander Senior, Anna P. Lam · 2022 · JMIR Diabetes
11. Use of Patient-Reported Outcomes for Assessing Diabetes Outcomes
    Hyon Kim, Kunal P. Shah, Christoph Buettner · 2022 · Endocrinology and Metabolism Clinics of North America
12. Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes
    Jenna B. Shapiro, Anthony T. Vesco, Michael S. Carroll, Jill A. Weissberg-Benchell · 2024 · Diabetes Technology & Therapeutics
13. Patient Satisfaction and Clinical Experience With the Tandem t:slim X2 With Control-IQ Technology Advanced Hybrid Closed-Loop Insulin Delivery System
    Lisa T. Meade, Adriane B. Marino, Madison A. Barrier, Madison H. Wilson · 2024 · Diabetes Spectrum
14. Cost–Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes
    Jolien De Meulemeester, Francesca Fiorentino, Nuno Picado, Margaretha M. Visser, Bart Keymeulen, Christophe E.M. De Block, Liesbeth Van Huffel, Youri Taes, Dominique Ballaux, Katrien Spincemaille et al. · 2025 · Diabetes Technology & Therapeutics
15. Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis
    Zekai Wu, Laure Alexandre‐Heymann, Maha Lebbar, Meryem Khadija Talbo, Aude Bandini, Tamanna Chahal, Caroline Grou, Virginie Messier, Valérie Boudreau, Anne‐Sophie Brazeau et al. · 2025 · Diabetes Obesity and Metabolism
16. Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes
    Nick S. Oliver · 2022 · Diabetes Therapy
17. Inpatient Use of Automated Insulin Delivery Systems
    Laya Chadalawada, Rohit Parab, Jenna M. Feeley, Michael S. Hughes, Francisco J. Pasquel, Georgia M. Davis · 2026 · Journal of Diabetes Science and Technology
18. Diabetes Without Math as Automation Advances: A Shifting Clinical Paradigm
    Pablo A. Mora, Kelly Postiglione Cook, Janice MacLeod · 2025 · Diabetes Technology and Obesity Medicine
19. An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy
    Alexandra Sawyer, Gregory P. Forlenza, Raj Paul Wadwa · 2025 · Expert Review of Medical Devices
20. Impact of automated insulin delivery (AID) systems on quality of life (QoL): Validation of the AID-QoL questionnaire
    Giuseppe Francesco Sferrazza Papa, Rossella Cannarella, Concetta Finocchiaro, Massimiliano Anzaldi, Gianfranco Gruttadauria, Donatella Lo Presti, Rosita Angela Condorelli, Sandro La Vignera, Aldo Eugenio Calogero · 2025 · Journal of Diabetes and its Complications
21. Automatisierte Insulinabgabesysteme (AID) in der Diabetestherapie: der neue Goldstandard?
    Sandra Schlüter, Dorothee Deiss, Delia Waldenmaier · 2025 · Die Diabetologie
22. Semaglutide Use With Automated Insulin Delivery in Adults With Type 1 Diabetes: Qualitative Analyses and Patient-reported Outcomes From a Randomized Controlled Trial
    Melissa‐Rosina Pasqua, Joelle Doumat, Michael A. Tsoukas, Ahmad Haidar · 2025 · Canadian Journal of Diabetes
23. Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence
    Hanna C. Jones, Steven L. Trawley, Alicia Josephine Jenkins, Richard J. MacIsaac, Yee Wen Kong, Dale Morrison, David Norman O'Neal · 2025 · Diabetes Technology & Therapeutics
24. The results of ProHCL: Patient-reported outcomes in people living with type 1 diabetes on hybrid closed-loop insulin pump therapy − experiences from the NHS England pilot
    Tomás Patrick Griffin, Jennifer Hagan, Radhika Chauhan, Thomas Simon James Crabtree, Dawn Ackroyd, Jackie Elliott, Parth Narendran, Zosanglura Bawlchhim, Emma G. Wilmot, Michelle Hadjiconstantinou et al. · 2026 · Diabetes Research and Clinical Practice
25. Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes
    JAYDE T. HOOVEN-DAVIS, Ingrid M. Libman, Scott D. Rothenberger, Christine A. March · 2026 · Diabetes Technology & Therapeutics
26. Cost‐effectiveness of control‐ IQ automated insulin delivery in adults with type 1 diabetes in Sweden
    JOHAN H. JENDLE, Nuno Picado, Carolina Bulhosa, Maaike Janssen, Rico Lepzien, Francesca Fiorentino, Sharon M. Wang, Bimal V. Patel, Charlotte Ekelund, Peter Adolfsson · 2026 · Diabetic Medicine
27. Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service
    Bilal Bashir, Panchami Elisaus, Victoria Chatzimavridou-Grigoriadou, Andrea Urwin, Alyson Chapman, Sheetal Ohol, Lynne Ann Findlow, Jody Foster, Rachel Harwood, Catherine Fullwood et al. · 2022 · Diabetic Medicine
28. Study protocol: a randomised controlled proof-of-concept real-world study – does maximising time in range using hybrid closed loop insulin delivery and a low carbohydrate diet restore the glucagon response to hypoglycaemia in adults with type 1 diabetes?
    Faye Baxter, Nicola Baillie, Shareen Forbes · 2022 · BMJ Open
29. Real‐world glycaemic outcomes in patients with type 1 diabetes using glucose sensors—Experience from a single centre in Dublin
    Robert E. Lyons, Roshaida Abdul Wahab, Sue Yee Goh, Cathy Breen, Amanda Rhynehart, Mary O'Scannail, Hannah Jade Kelly, Karl Neff, Donal Brendan O'Shea, Ronan J. Canavan et al. · 2024 · Endocrinology Diabetes & Metabolism
30. Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients
    Patricia Enes Romero, María Güemes, Blanca Guijo, Gabriel Ángel Martos‐Moreno, Jesús Pozo Román, Jesús Argente · 2024 · Endocrinología Diabetes y Nutrición (English ed )
31. Technology Issues
    Ravinder Jeet Kaur, Shafaq Rizvi, Yogish C. Kudva · 2021 · Wiley eBooks
32. Improved Glycemia and Quality of Life Among Loop users – Analysis of Real-World Data from a Single Centre (Preprint)
    Amy Morrison, Kimberley Chong, Valerie Lai, Kate Farnsworth, Peter Alexander Senior, Anna P. Lam · 2022
33. El sistema híbrido avanzado Tandem Control-IQ mejora el control glucémico en menores de 18 años con diabetes tipo 1 y el descanso nocturno de los cuidadores
    Andrés Mingorance Delgado, Fernando Lucas · 2022 · Endocrinología Diabetes y Nutrición
34. De psychologische aspecten van systemen met geautomatiseerde insulinetoediening in de type 1 diabeteszorg
    Giesje Nefs · 2023 · Nederlands Tijdschrift voor Diabetologie
35. Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
    Pranav M. Patel, Richard M. Abaniel, Natasha Dogra, Charles B. Lo, Marie A. Frazzitta, Naunihal S. Virdi · 2023
36. Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
    Pranav M. Patel, Richard M. Abaniel, Natasha Dogra, Charles B. Lo, Marie A. Frazzitta, Naunihal S. Virdi · 2023
37. Erste pädiatrische Nutzung eines AID-Systems mit automatischem Korrekturbolus in Deutschland
    Thekla von dem Berge, Sarah Biester, K Remus, Felix Reschke, Britta Klusmeier, Kerstin Adolph, Olga Kordonouri, Thomas Danne, Torben Biester · 2023 · Diabetologie und Stoffwechsel
38. Diabetes Technologies and the Human Factor
    Alon Liberman, Katharine D. Barnard-Kelly · 2024 · Diabetes Technology & Therapeutics
39. Sistemas de infusión automatizada de insulina en el tratamiento de la diabetes: beneficios, retos y consideraciones prácticas en la edad pediátrica
    Patricia Enes Romero, María Güemes, Blanca Guijo, Gabriel Ángel Martos‐Moreno, Jesús Pozo Román, Jesús Argente · 2024 · Endocrinología Diabetes y Nutrición
40. Association between perceived stigma and satisfaction with diabetes technologies among adolescents and young adults with type 1 diabetes: a cross-sectional study in Turkey
    Gülistan Çoban, Hamdiye Arda Sürücü · 2026 · PeerJ
41. Automated Insulin Delivery for Patients with Type 2 Diabetes: A Narrative Review
    Konstantinos Kitsios, Christina Trakatelli · 2026 · Current Diabetes Reviews
42. Existing Technologies in Diabetes Care
    Darshna M. Joshi, Hardik Bhatt, Himanshu K. Patel · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
43. Effects of automated insulin delivery systems on glucose control in subgroups of adults with type 1 diabetes in clinical practice over 2 years in Sweden
    Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, JOHAN H. JENDLE, Bengt-Olov Tengmark, Anna Folino, Marie Ekström, Marcus Lind · 2026 · Scientific Reports
44. Clinical effectiveness of different advanced hybrid closed-loop systems on time in tight range in adults with type 1 diabetes: A multicenter real-world study
    Ignacio González-Maroto, Jesús Moreno-Fernández, Pilar Isabel Beato-Víbora, Carmen Quirós · 2026 · Diabetes & Metabolism
45. Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review
    Laura Palermo, Joyeuse Senga, Patience Fakembe, Xi Zhu, Chris Walsh, Brenna Leslie, Rayzel M. Shulman, Justin Presseau, Maman Joyce Dogba, Ananya Banerjee et al. · 2026 · Diabetes Obesity and Metabolism
46. Priorities, Expectations, Perceptions of Time in Tight Range and Support Needs Relating to Closed‐Loop Therapy Among Adults With Type 1 Diabetes: The SELECT HCL Study
    Alexandros Leonidas Liarakos, ISKANDAR RAUF IDRIS, Emma G. Wilmot · 2026 · Diabetes Obesity and Metabolism
47. Automated Insulin Delivery Systems in Youth with Diabetes
    Mariam Mroweh, Samuel Thompson, Laya Ekhlaspour · 2026 · Endocrinology and Metabolism Clinics of North America